Fact CheckerSign in

NCT05414045Recruiting

Autologous Testicular Tissue Transplantation

Autologous Testicular Tissue Transplantation for Fertility Restoration

Source: ClinicalTrials.gov · Last updated 23 Apr 2026

Brief summary (registry, in English)

Freezing testicular tissue of prepubertal boys is a method for preserving spermatogonial stem cells in case of imminent gonadotoxic treatment during childhood. In case of total azoospermia or absence of spermatozoa that can be used for intra-cytoplasmic injection (ICSI) in adulthood, the investigators intend to perform the first in men autologous testicular tissue transplantation to restore fertility.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
5 (estimated)
First submitted
17 Feb 2022
Start date
22 Nov 2024
Primary completion date
29 Jul 2030
Lead sponsor
Universitair Ziekenhuis Brussel
Diseases
Thalassaemia
NCT number
NCT05414045

What you commit to

  • Study type: Interventional
  • Planned participants: 5
  • From 22 Nov 2024 to the primary completion date, 29 Jul 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Contra-indication for surgery

Other illness

  • Risk for presence of malignant cells in the testicular tissue
  • Instable psychological condition

Other

  • Contra-indication for pregnancy in the female partner
  • BMI \> 32
  • Heavy smoking (≥10 cigarettes/day)

Who the study is looking for

  • At least 18 years old
  • In case of female partner, age \< 43 year
  • Absence of spermatozoa that can be used for ICSI on 2 semen analyses
  • Normal standardised preliminary and preoperative bloodsampling results
  • Complete remission of the oncological or hematological disease
  • Approval of the treating oncologist or other specialist in case of non-oncological disease as reason for the testicular tissue preservation as a child
  • Risk for presence of malignant cells in testicular tissue is negligible (according to multidisciplinary assessment)
  • Presence of spermatogonial stem cells (positive MAGE staining) in one or two of the thawed fragments (If absence of spermatogonial stem cells in two of the thawed fragments, the case will be discussed multidisciplinary)
  • Written informed consent for the transplantation of cryopreserved testicular tissue and follow-up after the procedure and of children born eventually after this procedure

Criteria the registry did not label

  • The eligible patients opted as a prepubertal boy to enroll in the fertility preservation program and on the moment of cancer diagnosis or hematological disorder, their parents have agreed to cryopreserve testicular tissue for later autologous transplantation.

Age in the registry: 18 years to 50 years · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UZ Brussel Centre for Reproductive Medicine
Coordinator of this site? Confirm its status
BrusselsBelgiumRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.